✦ LIBER ✦

Efficacy of losartan vs. amlodipine in patients with chronic nondiabetic proteinuric nephropathy: glomerulaar study

✍ Scribed by Carlos Fernandez-Andrade; Manuel Praga; Manolo Arias; Rafael Poveda; Josep Mora; Josep M. Campistol; Mati Valles; Francisco Rivera; Josep M. Galceran

Book ID: 117601329
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 37 KB
Volume: 15
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(02)02761-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E099 A randomized, double-blind, paralle

E099 A randomized, double-blind, parallel study of the safety and antihypertensive efficacy of losartan vs amlodipine in patients with mild to moderate hypertension and impaired renal function

✍ C. Fernández-Andrade; R. Delgado; P. Aranda; J. Aranda; Santos Casado; A. Ortiz; 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Interim evidence of the renoprotective e

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

✍ Yasuhiko Iino; Matsuhiko Hayashi; Tetsuya Kawamura; Tatsuo Shiigai; Yasuhiko Tom 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 613 KB

1353 A PHASE IIB STUDY OF THE EFFICACY A

1353 A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF LB80380 VS ENTECAVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B

✍ Lai, C.L.; Ahn, S.H.; Lee, K.S.; Um, S.H.; Cho, M.; Yoon, S.K.; Lee, J.W.; Park, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Efficacy of triple combination olmesarta

Efficacy of triple combination olmesartan 20 mg amlodipine 5 mg hydrochlorthiazide 12.5 mg (oah) vs dual combination of olmesartan 20 mg amlodipine 5 mg (oa) in patients with hypertension, a double blind, randomized, comparative study

✍ Gurudutt Nayak; Harsha KP; Jayanthi CR; Sreepada Bhat; Umakanth Patil; Narendra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Scientific rationale and study design of

Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C

✍ J. McHutchison; M. Sulkowski 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

1181 A phase III, partially double-blind

1181 A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2A (40KD) (PEGSYS®) alone or in combination with lamivudine vs lamivudine in 546 patients with HBEAG-negative/anti-HBE-positive chronic hepatitis B

✍ MARCELLIN, P; LAU, G; BONINO, F; FARCI, P; HADZIYANNIS, S; JIN, R; LU, Z; PIRATV 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB